Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo

Robert H Paul1, Kyu S Cho1, Andrew C Belden1

  • 1Missouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.

AIDS (London, England)
|January 3, 2020
PubMed

Insights

Machine learning accurately predicts neurocognitive trajectories in children with perinatal HIV (pHIV). Key predictors include HIV disease severity, immune markers, mental health, and hematocrit levels, enabling early risk identification.

Area of Science:

  • Pediatric infectious diseases
  • Neuroscience
  • Machine learning applications in healthcare

Background:

  • Children with perinatal HIV (pHIV) face risks of neurocognitive impairment.
  • Predicting neurocognitive trajectories is crucial for timely intervention.

Purpose of the Study:

  • To develop a predictive model for neurocognitive trajectories in children with pHIV.
  • Identify key predictors of neurocognitive development in this population.

Main Methods:

  • Machine learning (Gradient-boosted multivariate regressions) applied to longitudinal data from 285 children with pHIV.
  • Analysis included demographic, clinical, immune, mental health, and complete blood count (CBC) data.
  • Models were validated using five-fold cross-validation.

Main Results:

  • Baseline models achieved an average AUC of 79%, identifying HIV severity and immune markers as key predictors.
  • Longitudinal models improved predictive accuracy to 87-90% AUC.
  • Mental health problems and hematocrit levels emerged as significant longitudinal predictors, with novel interactions identified.

Conclusions:

  • Machine learning is feasible for identifying children with pHIV at risk for neurocognitive difficulties.
  • Interactions between HIV disease and mental health are early indicators of later neurocognitive challenges.
Abstract